| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3288 | |||||||||||||||||||||||
| Submitter : | Ms. sarah green | Date & Time: | 12/15/2006 08:12:12 | |||||||||||||||||||||
| Organization : | Ms. sarah green | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| While I support research and the tireless efforts of finding cures and vaccines for these viral infections that affect our world, I do not support the use of unethical means such as cell lines from aborted individuals. I believe there are moral implications with that vein of research and vaccine. Due to these moral and ethical concerns, I encourage the FDA to amend the guidelines in how to manufacture vaccines. | ||||||||||||||||||||||||